SmartTRAK reports that strong sales of spine robotic and enabling technology in Q121 continue to move the ball forward in the adoption curve. Companies are noting an inflection point on the pathway of these technologies becoming mainstream with centers buying multiple robots, and community and university hospitals adopting them.
Among the many topics covered in detail in our comprehensive Q121 CAS Spine Market Recap* are:
RapidAI President and CEO Don Listwin discusses how advances in AI-based imaging, workflow and products are improving stroke care in an interview with SmartTRAK
RapidAI, the market leader in brain imaging analysis, processed more than 1MM stroke imaging scans in 2020 alone, up 100% year-over-year, despite COVID-19. Using AI-based software and decision support tools, the Company is helping stroke professionals identify and diagnose more cerebrovascular disorders than ever before, driving double-digit growth in stroke procedures for some hospitals. Although challenges remain in getting the right patient to the right hospital in a timely fashion, RapidAI is working to improve outcomes and the stroke systems of care through improved workflow and messaging technologies, AI-based analytics and new products, such as non-contrast scans that will improve decision-making at some of the smaller spoke hospitals and prevent unnecessary transfers to comprehensive stroke centers.
To find out more, including RapidAI’s plans for indications outside of stroke care, SmartTRAK interviewed RapidAI President and CEO Don Listwin. To listen to the interview, recorded via Uberconference, click on the following video (25:40 min). A link to download a transcript of the interview is also provided below.
Despite an ongoing slowdown in elective procedures due to COVID, enabling technology continued to experience strong demand in orthopedics in Q121. Since the vast majority of patients who put off elective procedures due to the pandemic are expected to come back into the funnel, SmartTRAK anticipates that robotic and other technologies will continue to gain traction well into next year and beyond.
Changing market dynamics over the past ten years has not held back the robust Skin Substitute/CTP market.
As SmartTRAK celebrates its 10-year anniversary covering AWC and the Biologics area, we look back at the market drivers, products and players to see how the US Skin Substitute market has changed over the last decade. We also look ahead to see what is in store for the Skin Substitute market, which is projected to reach $1.64B in 2025E.
The following is a preview of our Wound Biologics market retrospective. The full article, available on SmartTRAK, features our industry experts discussing and analyzing these changes and trends in detail.
In spite of various headwinds, a strong uptick in surgical procedures and business activities in March was the slingshot effect needed to propel the US Orthobio Market into double-digit percentage growth for Q121.
In spite of the headwinds from a resurgence of COVID-19 cases in Q420 that spilled over to the early part of Q121 and winter storms of historical proportions in February, a strong uptick in elective surgical procedures in March was the slingshot effect the US Orthobio Market needed to propel it.
Among the many topics covered in detail in our comprehensive Q121 US Orthobio Market Recap* are:
The first quarter of 2021 felt like riding a car with square wheels, but ahead, the road looks smoother.
Coming out of a rough Q420 that sent the US Joint Fluid Replacement market players spinning at dizzying speed around the roulette wheel, the first quarter of 2021 gave them a bumpy ride on the road to COVID-19 recovery. As if a resurgence of positive COVID cases in late Q420 spilling into Q121 was not enough of a headwind, in mid-February, winter storms Uri and Viola landed a one-two hit across North America.
Among the many topics covered in detail in our comprehensive Q121 US Joint Fluid Replacement Market Recap* are:
In an interview with SmartTRAK, André Mercanzini, founder and CEO of Aleva Neurotherapeutics, discusses the Company's next-gen DBS System and improving outcomes via miniaturization and MEMS-based technologies.
A return to positive growth for the quarter, but gains lag behind pre-COVID-19 levels.
The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.
Among the many topics covered in detail in our comprehensive Q121 US Infection Prevention - Vascular Access (VA) Adjunct Products Market Recap* are:
Advanced Wound Care begins to stabilize as in-person visits increase and elective procedures rebound.
For Q121, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up +6.2%, boosted by a strong performance in Biologics, with 3M maintaining the number one position in the AWC space.
Among the many topics covered in detail in our comprehensive Q121 AWC Market Recap* are:
As the COVID-19 workplace restrictions ease up, the MedTech industry continues to progress with product innovation and plans for the future. In July, AOSSM and AANA are partnering for a combined annual meeting, the first in-person meeting for both since the start of the pandemic. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the Sports Medicine market.
The following is just a small sampling of recent Sports Medicine related updates from around the world compiled, reviewed and posted in real time by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life Sciences industry.
Patents:
Biomet Sports Medicine (ZBH) was issued US Patent “Method and apparatus for forming a self-locking adjustable loop”, describing methods and apparatus for forming a self-locking adjustable loop. 11,039,826
Cannabinoid for Sports Med Applications
Precision Biologic’s US Patent Application “METHODS OF USING CANNABINOID COMPOSITIONS IN SPORTS MEDICINE APPLICATIONS” was published. 20210128521
Stryker (Ivy Sports Medicine LLC) was issued US Patent “System and method for all-inside suture fixation for implant attachment and soft tissue repair”, describing an all-inside soft tissue repair device. 10,932,769
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.